World Vaccine Congress China 2008 (WCV-2008)
|Event Date/Time: Dec 01, 2008||End Date/Time: Dec 05, 2008|
|Registration Date: Nov 15, 2008|
|Early Registration Date: Jun 30, 2008|
|Abstract Submission Date: Oct 15, 2008|
|Paper Submission Date: Oct 15, 2008|
Congress Dates: December 1-5, 2008. Baiyun International Convention Center, Guangzhou, China
Exhibition Dates: December 2-4, 2008. Baiyun International Convention Center, Guangzhou, China
Congress Website: http://www.bitlifesciences.com/WCV-2008
BIT Life Sciencesâ€™ 1st Annual World Vaccine Congress 2008, with a theme of "Building an Olympian Meeting Platform for Vaccine World, which will be held during December 1-5, 2008 at Baiyun International Convention Center, Guangzhou China. The Congress will be the largest meeting devoted exclusively to the research on vaccines and asociated technologies for disease prevention and treatment. There are 78 sessions and 5 workshops will be included in the congress. It will bring you the No. 1 largest speaker clusters and most influential event program in vaccine meeting history across the world. It aims at building a complete network for whole vaccine world.
The breathtaking and ambitious program is designed to cover almost all areas in frontier of Vaccinology, new technology innovations, vaccine R &D or discovery, regulatory, public health, safety and ethic issues, clinical practices, finance and business development, vaccine manufacturers and Procurement, equipment sellers and buyers, service and consulting providers, enabled technology and ready-to-go product licensing. Besides, BITâ€™s World Vaccine Congress will also invite NGO health strategy planners to provide their alternative expert views on securing safe vaccines and educations for the public. Itâ€™s believed that this annual congress of vaccine will provide enormous collaboration and insight information exchange opportunities. The first annual World Vaccine Congress will provide you a panorama update on today and next generation human and veterinary vaccines figured by
-Scheduling >600 oral presentations and panel
-Showcasing 200 poster and 100 expositions
-Targeting 1500-2000 audiences from up to 80 countries
-Providing five training courses to serve educational purposes
-Arranging round table network for business and market development
-Organizing 2 Art and Culture Events
-Fostering friendship through a Warm Tour in the holly season to the ever-spring regions in southern China
As the top one information provider in Life Sciences in China, BIT Life Sciences hopes such an initiative can catalyze the generating One-For-All meeting place of Vaccines not only for Asia but also for the whole world. With its novel Videolization Technology to be launched later this year, BIT Life Sciences' World Vaccine Congress will guarantee to maximize the exposure for you to both professional society and public community no mater you are scientific innovators, decision makers, entrepreneurs and even laymen. The organizers wish BITâ€™s Annual World Vaccine Congress can serve as the visualized "Science" and "Nature" Magazines for all parties interested in vaccine related issues.
The five day main conference along with 3 day tech tour to the most beautiful sightseeing place, Guilin, will provide you unforgettable meeting experiences in China.
Key speakers include:
Dr. John B Robbins
Senior Investigator, National Institute of Child Health & Human Development, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA
Dr. John D. Clemens Director General, International Vaccine Institute (IVI), Korea
Dr. Steven M. Ferguson
Director, Division of Technology Development and Transfer U.S. National Institutes of Health
Dr. Donald P. Francis
Former President & Co-founder VaxGen, Inc.
Executive Director and Co-founder, Global Solutions for Infectious Diseases, USA
Dr. Kai Chen
Vice President, Business Development IOMAI Corporation, USA
Dr. John W. Shiver
Vice President, Worldwide Basic Research Franchise Head, Vaccines Merck and Co., Inc. USA
Dr. Peter Khoury
Vice President, Global Marketing Baxter Bioscience-Vaccines, USA
Dr. Luc Aujame
Director, External R&D, Sanofi Pasteur, France
More than 70 distinguished Session Keynote Speakers and other 500+ high profile speakers from more than 80 countries are lining up.
Chief Technology Officer
BIT Life Sciences, Inc.
26 Gaoneng St., F4
Dalian Hightech Zone